Fragment screening against Schistosoma mansoni dihydroorotate dehydrogenase: a modern approach for drug discovery

Vol. 1, 2019 - 112704
Poster only
Favorite this paper
How to cite this paper?
Abstract

Fragment screening has emerged as an important tool in the pipeline of drug discovery. By using compounds of low molecular weight, it is possible to cover a broader range of the chemical space with fewer compounds. This project focuses on the use of the fragment-based lead discovery technique to search for novel chemical entities as precursors of selective and potent inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase (SmDHODH) with drug-like properties. Schistosoma mansoni is among the five species responsible for the schistosomiasis. DHODH is a flavoenzyme that catalyzes the stereospecific oxidation of (S)-dihydroorotate (DHO) to orotate, the selective inhibition of DHODH has been exploited for the development of innovative therapeutic strategies. We have recently developed a reproducible crystallization condition, which will be used to map the structural basis of interaction between SmDHODH and selective inhibitors. Fragment screening against different libraries allowed us to identify SmDHODH inhibitor in the nanomolar range.

Track
  • 1. Strategies in Drug Design
Keywords
Fragment screening
Schistosoma mansoni dihydroorotate dehydrogenase (SmDHODH)
Crystallography
Schistosomiasis